MIE-101 is currently in late-stage preclinical development and our goal is to advance MIE-101 into veterinary studies in 2022

goal is to advance  -- well with the next sentence it seems that youre going to take the ENTIRE 2022 to " advance "

and into Phase I clinical trials in 2023, provided we are able to raise sufficient funding.

Phase I clinical trials - " MAYBE " in 2023 if we can find people in 2022 to FUND US and our families thru 2022 and 2023 and then we'll see if we have enough to 'maybe' take this dream into 2023 ... remember now investors - ALL dependent - provided we are able to raise sufficient funding

So investors - IT's ALL on you - ball in your court, while we wait to SEE the Money

So we say: INVESTORS SHOW US THE MONEY

oh - we cant promise ANY Money making Contracts in 2022 or 2023

we are not sure what will happen in 2024 - other then OUR Houses and Fast Cars will for sure be paid off and our island vacation homes

Again

INVESTORS SHOW US THE MONEY

" provided we are able to raise sufficient funding "